home All News open_in_new Full Article

Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025

Preclinical data highlight the potential of Aspect’s adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency VANCOUVER, British Columbia — Aspect Biosystems, a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) as a new category in regenerative medicine, today announced new preclinical data at ENDO 2025, the Endocrine Society’s […]


today 10 h. ago attach_file Other

attach_file Economics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Economics
attach_file Other
attach_file Society
attach_file Other
attach_file Economics
attach_file Economics
attach_file Transport
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Events


ID: 162131574
Add Watch Country

arrow_drop_down